Cargando…
Probiotic Limosilactobacillus fermentum GR-3 ameliorates human hyperuricemia via degrading and promoting excretion of uric acid
Probiotics have demonstrated the potential to ameliorate hyperuricemia in animals, but their effectiveness and mechanism of action in humans has been understudied. A randomized, double-blinded, controlled research was conducted with 120 volunteers, who consume either a probiotic yogurt containing a...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556918/ https://www.ncbi.nlm.nih.gov/pubmed/36248735 http://dx.doi.org/10.1016/j.isci.2022.105198 |
_version_ | 1784807182820179968 |
---|---|
author | Zhao, Shuai Feng, Pengya Hu, Xiaogang Cao, Wenjuan Liu, Pu Han, Huawen Jin, Weilin Li, Xiangkai |
author_facet | Zhao, Shuai Feng, Pengya Hu, Xiaogang Cao, Wenjuan Liu, Pu Han, Huawen Jin, Weilin Li, Xiangkai |
author_sort | Zhao, Shuai |
collection | PubMed |
description | Probiotics have demonstrated the potential to ameliorate hyperuricemia in animals, but their effectiveness and mechanism of action in humans has been understudied. A randomized, double-blinded, controlled research was conducted with 120 volunteers, who consume either a probiotic yogurt containing a UA-degrading strain Limosilactobacillus fermentum GR-3 or a conventional yogurt for 2 months, to investigate probiotic yogurt helped decrease uric acid levels in the at-risk human population. Serum UA levels showed that the probiotic yogurt caused a significant decrease than the consumption of conventional yogurt (26.2% ± 2.3% vs. 8.6% ± 1.1%), and contributed to the UA excretion in the feces and urine (7.4% ± 2.1% and 13.8% ± 3.4%, respectively, 1.9% ± 1.1% and 5.1% ± 2.2%, respectively). Metabolomics and microbial community analysis showed a positive correlation with enhanced anti-inflammation of the host. Our findings suggest an effective and economical therapeutic adjuvant in treating hyperuricemia. |
format | Online Article Text |
id | pubmed-9556918 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-95569182022-10-14 Probiotic Limosilactobacillus fermentum GR-3 ameliorates human hyperuricemia via degrading and promoting excretion of uric acid Zhao, Shuai Feng, Pengya Hu, Xiaogang Cao, Wenjuan Liu, Pu Han, Huawen Jin, Weilin Li, Xiangkai iScience Article Probiotics have demonstrated the potential to ameliorate hyperuricemia in animals, but their effectiveness and mechanism of action in humans has been understudied. A randomized, double-blinded, controlled research was conducted with 120 volunteers, who consume either a probiotic yogurt containing a UA-degrading strain Limosilactobacillus fermentum GR-3 or a conventional yogurt for 2 months, to investigate probiotic yogurt helped decrease uric acid levels in the at-risk human population. Serum UA levels showed that the probiotic yogurt caused a significant decrease than the consumption of conventional yogurt (26.2% ± 2.3% vs. 8.6% ± 1.1%), and contributed to the UA excretion in the feces and urine (7.4% ± 2.1% and 13.8% ± 3.4%, respectively, 1.9% ± 1.1% and 5.1% ± 2.2%, respectively). Metabolomics and microbial community analysis showed a positive correlation with enhanced anti-inflammation of the host. Our findings suggest an effective and economical therapeutic adjuvant in treating hyperuricemia. Elsevier 2022-09-28 /pmc/articles/PMC9556918/ /pubmed/36248735 http://dx.doi.org/10.1016/j.isci.2022.105198 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Zhao, Shuai Feng, Pengya Hu, Xiaogang Cao, Wenjuan Liu, Pu Han, Huawen Jin, Weilin Li, Xiangkai Probiotic Limosilactobacillus fermentum GR-3 ameliorates human hyperuricemia via degrading and promoting excretion of uric acid |
title | Probiotic Limosilactobacillus fermentum GR-3 ameliorates human hyperuricemia via degrading and promoting excretion of uric acid |
title_full | Probiotic Limosilactobacillus fermentum GR-3 ameliorates human hyperuricemia via degrading and promoting excretion of uric acid |
title_fullStr | Probiotic Limosilactobacillus fermentum GR-3 ameliorates human hyperuricemia via degrading and promoting excretion of uric acid |
title_full_unstemmed | Probiotic Limosilactobacillus fermentum GR-3 ameliorates human hyperuricemia via degrading and promoting excretion of uric acid |
title_short | Probiotic Limosilactobacillus fermentum GR-3 ameliorates human hyperuricemia via degrading and promoting excretion of uric acid |
title_sort | probiotic limosilactobacillus fermentum gr-3 ameliorates human hyperuricemia via degrading and promoting excretion of uric acid |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556918/ https://www.ncbi.nlm.nih.gov/pubmed/36248735 http://dx.doi.org/10.1016/j.isci.2022.105198 |
work_keys_str_mv | AT zhaoshuai probioticlimosilactobacillusfermentumgr3ameliorateshumanhyperuricemiaviadegradingandpromotingexcretionofuricacid AT fengpengya probioticlimosilactobacillusfermentumgr3ameliorateshumanhyperuricemiaviadegradingandpromotingexcretionofuricacid AT huxiaogang probioticlimosilactobacillusfermentumgr3ameliorateshumanhyperuricemiaviadegradingandpromotingexcretionofuricacid AT caowenjuan probioticlimosilactobacillusfermentumgr3ameliorateshumanhyperuricemiaviadegradingandpromotingexcretionofuricacid AT liupu probioticlimosilactobacillusfermentumgr3ameliorateshumanhyperuricemiaviadegradingandpromotingexcretionofuricacid AT hanhuawen probioticlimosilactobacillusfermentumgr3ameliorateshumanhyperuricemiaviadegradingandpromotingexcretionofuricacid AT jinweilin probioticlimosilactobacillusfermentumgr3ameliorateshumanhyperuricemiaviadegradingandpromotingexcretionofuricacid AT lixiangkai probioticlimosilactobacillusfermentumgr3ameliorateshumanhyperuricemiaviadegradingandpromotingexcretionofuricacid |